GEV.US

1,078.54

+1.71%↑

GE

290

+2.46%↑

RTX

176.23

+2.29%↑

BA

229.21

+2.44%↑

UNP

269.74

+1.98%↑

GEV.US

1,078.54

+1.71%↑

GE

290

+2.46%↑

RTX

176.23

+2.29%↑

BA

229.21

+2.44%↑

UNP

269.74

+1.98%↑

GEV.US

1,078.54

+1.71%↑

GE

290

+2.46%↑

RTX

176.23

+2.29%↑

BA

229.21

+2.44%↑

UNP

269.74

+1.98%↑

GEV.US

1,078.54

+1.71%↑

GE

290

+2.46%↑

RTX

176.23

+2.29%↑

BA

229.21

+2.44%↑

UNP

269.74

+1.98%↑

GEV.US

1,078.54

+1.71%↑

GE

290

+2.46%↑

RTX

176.23

+2.29%↑

BA

229.21

+2.44%↑

UNP

269.74

+1.98%↑

Search

CryoPort Inc

Slēgts

SektorsRūpniecība

10.25 4.81

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

9.69

Max

10.27

Galvenie mērījumi

By Trading Economics

Ienākumi

-17M

-24M

Pārdošana

1.2M

45M

Peļņas marža

-51.98

Darbinieki

684

EBITDA

-4.1M

-3.7M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+26.24% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 4. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

110M

521M

Iepriekšējā atvēršanas cena

5.44

Iepriekšējā slēgšanas cena

10.25

Ziņu noskaņojums

By Acuity

50%

50%

215 / 403 Rangs Industrials

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

CryoPort Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 30. apr. 23:08 UTC

Peļņas

Australia's ANZ Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

2026. g. 30. apr. 23:07 UTC

Peļņas

Australia's Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

2026. g. 30. apr. 22:20 UTC

Peļņas

Australia's ANZ Raises 1st Half Profit 9%, Warns of Coming Iran Impacts

2026. g. 30. apr. 23:48 UTC

Tirgus saruna

Nikkei May Rise After Gains on Wall Street -- Market Talk

2026. g. 30. apr. 23:47 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 30. apr. 23:47 UTC

Tirgus saruna

Coles's Earnings Views Likely to Edge Down Despite Positives -- Market Talk

2026. g. 30. apr. 23:27 UTC

Tirgus saruna

Liontown Lithium Recovery Expected to Improve -- Market Talk

2026. g. 30. apr. 23:22 UTC

Peļņas

Apple's Incoming CEO John Ternus Makes Appearance as Company Bests Expectations -- Update

2026. g. 30. apr. 23:20 UTC

Tirgus saruna

Wildcat Resources Stands Out Among Lithium Developers -- Market Talk

2026. g. 30. apr. 22:52 UTC

Peļņas

Australia's ANZ Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

2026. g. 30. apr. 22:33 UTC

Peļņas

Zhejiang Expressway: Impairment Loss Weighed on Net >0576.HK

2026. g. 30. apr. 22:32 UTC

Peļņas

Zhejiang Expressway 1Q Net CNY1.31B Vs. Net CNY1.48B >0576.HK

2026. g. 30. apr. 22:32 UTC

Peļņas

Zhejiang Expressway 1Q Rev CNY5.32B Vs. CNY4.36B >0576.HK

2026. g. 30. apr. 22:24 UTC

Iegādes, apvienošanās, pārņemšana

Mineral Resources: Also Reflects Time Needed to Implement Corporate Restructure For JV

2026. g. 30. apr. 22:23 UTC

Iegādes, apvienošanās, pārņemšana

Mineral Resources: Revised Timetable Reflects Time Needed to Get Regulatory Approvals

2026. g. 30. apr. 22:23 UTC

Iegādes, apvienošanās, pārņemšana

Mineral Resources: Now Expects Deal to Complete in 1H FY2027

2026. g. 30. apr. 22:23 UTC

Iegādes, apvienošanās, pārņemšana

Mineral Resources: Executes Key Formal Agreements With Posco on Stake Sale

2026. g. 30. apr. 22:11 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 30. apr. 22:11 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 30. apr. 22:11 UTC

Tirgus saruna

Apple Says Demand for Lower-Cost Laptop is Off the Charts -- Market Talk

2026. g. 30. apr. 22:05 UTC

Peļņas

Australia's ANZ Raises 1H Profit 9%, Warns of Coming Iran Impacts

2026. g. 30. apr. 21:57 UTC

Peļņas

ANZ CEO: Increase in Collective Provisions Reflects Risk>ANZ.AU

2026. g. 30. apr. 21:56 UTC

Peļņas

ANZ CEO: Minimal Impact on ANZ's Credit, Capital, Liquidity>ANZ.AU

2026. g. 30. apr. 21:56 UTC

Peļņas

ANZ CEO: No Material Increase in New Cases of Household Hardship>ANZ.AU

2026. g. 30. apr. 21:55 UTC

Peļņas

ANZ CEO: Households Entered Crisis With Generally Strong Balance Sheets>ANZ.AU

2026. g. 30. apr. 21:54 UTC

Peļņas

ANZ CEO: No Material Change in Overall Corporate Borrowing Behavior >ANZ.AU

2026. g. 30. apr. 21:54 UTC

Peļņas

ANZ CEO: Corporate Customers Have Been Building Capital, Liquidity Against Shocks>ANZ.AU

2026. g. 30. apr. 21:53 UTC

Peļņas

ANZ CEO: Much of Iran Conflict's Potential Impact Remains Ahead>ANZ.AU

2026. g. 30. apr. 21:49 UTC

Peļņas

ANZ Group 1H Total Operating Income A$11.20B Vs. A$10.995B>ANZ.AU

2026. g. 30. apr. 21:49 UTC

Peļņas

ANZ Group 1H Customer Deposits A$770.7B Vs. A$756.6B>ANZ.AU

Salīdzinājums

Cenas izmaiņa

CryoPort Inc Prognoze

Cenas mērķis

By TipRanks

26.24% augšup

Prognoze 12 mēnešiem

Vidējais 12.75 USD  26.24%

Augstākais 15 USD

Zemākais 9.5 USD

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CryoPort Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

7 ratings

6

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

5.615 / N/AAtbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Weak Bullish Evidence

Noskaņojums

By Acuity

215 / 403 Rangs Rūpniecība

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par CryoPort Inc

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
help-icon Live chat